Brawn Biotech Quarterly Results for Trading Insights

BRAWN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QMar 2023
Quarterly Results

Brawn Biotech Quarterly Results Key Highlights

  • Operating Margin of 25.0% in Mar 2023 (+58.0pp vs Jun 2023)
  • Earnings Per Share of ₹0.47 in Mar 2023 (+687.5% vs Jun 2023)

Brawn Biotech Quarterly Results Analysis

Metric Mar 2023 Jun 2023 Jun 2022 QoQ YoY
Revenue (₹ Cr) 0 0 0 - -
Net Profit (₹ Cr) 0 0 0 - -
EBITDA (₹ Cr) 0 0 0 - -
EPS (₹) 0.47 -0.08 0.05 - -
Operating Margin (%) 25.0% -33.0% 25.0% - -

Brawn Biotech Share Price Trend Around Quarterly Results

Visualize Brawn Biotech's 1-year price movement across quarterly results — ideal for logging trades in Brawn Biotech share price chart using Tickjournal. All values in ₹.

Related Pages for Brawn Biotech

Additional stock information and data for BRAWN

Brawn Biotech ownership structure
BRAWN yearly price range
BRAWN investment value
BRAWN earnings multiple
Brawn Biotech share price chart
BRAWN share price data
Brawn Biotech market worth
BRAWN cash flow statement

Profitability Ratios

Operating Margin 25.0%

Balance Sheet Highlights

Total Assets ₹21 Cr
Total Equity ₹3 Cr
Current Assets ₹18 Cr
Current Liabilities ₹8 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹22.99
Exchange BSE
Last Updated Jan 09, 2026

Revenue Trend (₹ Cr)

Jun 2022 0
Jun 2023 0
Mar 2023 0

Net Profit Trend (₹ Cr)

Jun 2022 0
Jun 2023 0
Mar 2023 0

Operating Margin Trend (%)

Jun 2022 25.0%
Jun 2023 -33.0%
Mar 2023 25.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Brawn Biotech quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹417,052.40 Cr 1729.9 14,875 3,125 +10.8% - 21.0% 133.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6616.5 2,860 689 +7.1% - 24.1% 254.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 3963.4 3,219 591 +11.3% - 18.4% 226.0
Cipla
Sept 2025 		₹118,572.82 Cr 1465.7 7,716 1,353 +12.0% - 17.5% 87.6
Dr Reddys Laborator…
Sept 2025 		₹100,998.62 Cr 1210.1 9,135 1,337 +1.1% - 14.6% 74.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores